| Edgewise Therapeutics Inc | 15 518 492 | 488,8 M $ | |
| Enliven Therapeutics Inc | 7 959 538 | 312 M $ | |
| Eli Lilly & Co | 236 800 | 217,8 M $ | |
| Boston Scientific Corp | 2 382 100 | 149,5 M $ | |
| Sionna Therapeutics Inc | 3 530 702 | 141,5 M $ | |
| MBX Biosciences Inc | 3 637 887 | 108,6 M $ | |
| Corvus Pharmaceuticals Inc | 7 165 006 | 104,8 M $ | |
| Argenx SE | 136 900 | 100 M $ | |
| Edwards Lifesciences Corp | 1 230 600 | 98,5 M $ | |
| Intuitive Surgical Inc | 208 700 | 96,2 M $ | |
| Compass Therapeutics Inc | 15 219 994 | 80,5 M $ | |
| Merck & Co Inc | 663 400 | 79,8 M $ | |
| Structure Therapeutics Inc | 1 475 403 | 71,1 M $ | |
| ArriVent Biopharma Inc | 3 027 328 | 69,8 M $ | |
| Disc Medicine Inc | 1 067 550 | 68,3 M $ | |
| ARS Pharmaceuticals Inc | 8 288 510 | 66,6 M $ | |
| CG oncology Inc | 948 267 | 64,2 M $ | |
| Stryker Corp | 182 500 | 60 M $ | |
| Bristol-Myers Squibb Co | 925 000 | 56,1 M $ | |
| Mineralys Therapeutics Inc | 2 052 900 | 55,6 M $ | |
| Praxis Precision Medicines Inc | 172 500 | 55,6 M $ | |
| Pfizer Inc | 1 946 500 | 54,7 M $ | |
| Dyne Therapeutics Inc | 2 917 884 | 52,9 M $ | |
| Natera Inc | 262 000 | 52,4 M $ | |
| Abivax SA | 465 700 | 51,9 M $ | |
| Upstream Bio Inc | 5 693 589 | 51,2 M $ | |
| Danaher Corp | 265 800 | 50,4 M $ | |
| Caris Life Sciences Inc | 2 806 811 | 50,2 M $ | |
| Ascendis Pharma A/S | 181 977 | 41,6 M $ | |
| Shattuck Labs Inc | 6 306 127 | 40,5 M $ | |
| Guardant Health Inc | 435 200 | 40,2 M $ | |
| Alnylam Pharmaceuticals Inc | 119 000 | 39,4 M $ | |
| Prelude Therapeutics Inc | 10 909 256 | 37,3 M $ | |
| Crinetics Pharmaceuticals Inc | 999 000 | 36,3 M $ | |
| Axsome Therapeutics Inc | 213 921 | 36,2 M $ | |
| ORIC Pharmaceuticals Inc | 2 693 929 | 34,1 M $ | |
| Elevance Health Inc | 114 700 | 33,6 M $ | |
| Relmada Therapeutics Inc | 4 715 864 | 32,8 M $ | |
| Forte Biosciences Inc | 1 196 955 | 31 M $ | |
| Trevi Therapeutics Inc | 2 454 400 | 29,3 M $ | |
| Esperion Therapeutics Inc | 10 570 300 | 29 M $ | |
| NeuroPace Inc | 2 096 527 | 27,6 M $ | |
| Rhythm Pharmaceuticals Inc | 314 100 | 27,3 M $ | |
| Thermo Fisher Scientific Inc | 46 500 | 22,9 M $ | |
| Syndax Pharmaceuticals Inc | 962 300 | 22,5 M $ | |
| BrightSpring Health Services Inc | 497 800 | 21,2 M $ | |
| Lexeo Therapeutics Inc | 3 602 450 | 20,7 M $ | |
| Sutro Biopharma Inc | 801 144 | 20 M $ | |
| Nektar Therapeutics | 275 000 | 19,8 M $ | |
| Krystal Biotech Inc | 69 100 | 17,8 M $ | |
| Palvella Therapeutics Inc | 134 600 | 16,8 M $ | |
| Corbus Pharmaceuticals Holdings Inc | 1 737 287 | 16,3 M $ | |
| Vera Therapeutics Inc | 369 596 | 14,9 M $ | |
| Q32 Bio Inc | 2 252 987 | 14,5 M $ | |
| Aadi Bioscience Inc | 4 166 000 | 14,4 M $ | |
| Amgen Inc | 39 900 | 14 M $ | |
| Alignment Healthcare Inc | 791 000 | 13,9 M $ | |
| EyePoint Inc | 1 069 147 | 13,8 M $ | |
| Janux Therapeutics Inc | 983 600 | 13,7 M $ | |
| BioCryst Pharmaceuticals Inc | 1 425 200 | 13,6 M $ | |
| Bicara Therapeutics Inc | 667 300 | 13,3 M $ | |
| BioAge Labs Inc | 711 811 | 12,4 M $ | |
| Cogent Biosciences Inc | 322 100 | 12,4 M $ | |
| Alumis Inc | 548 163 | 12,1 M $ | |
| Regeneron Pharmaceuticals, Inc. | 14 700 | 11,4 M $ | |
| Carlsmed Inc | 1 252 600 | 11,3 M $ | |
| Biogen Inc | 61 600 | 11,3 M $ | |
| Keros Therapeutics Inc | 759 155 | 8,4 M $ | |
| Gilead Sciences Inc | 59 600 | 8,3 M $ | |
| Heron Therapeutics Inc | 9 816 940 | 7,9 M $ | |
| AVALO THERAPEUTICS INC | 475 165 | 7,1 M $ | |
| Tectonic Therapeutic Inc | 226 600 | 7 M $ | |
| Adicet Bio Inc | 1 027 944 | 7 M $ | |
| Compass Pathways plc | 1 150 646 | 6,4 M $ | |
| ALX Oncology Holdings Inc | 2 866 256 | 5,7 M $ | |
| Artivion Inc | 151 000 | 5,5 M $ | |
| InspireMD, Inc. | 3 133 405 | 5,1 M $ | |
| Revolution Medicines Inc | 52 000 | 5,1 M $ | |
| Protagonist Therapeutics Inc | 42 100 | 4,4 M $ | |
| Palisade Bio Inc | 2 333 000 | 4,1 M $ | |
| Alto Neuroscience Inc | 167 500 | 3,8 M $ | |
| Savara Inc | 635 000 | 3,5 M $ | |
| Cullinan Therapeutics Inc | 243 006 | 3,5 M $ | |
| PTC Therapeutics Inc | 49 100 | 3,3 M $ | |
| LifeStance Health Group Inc | 500 000 | 3,2 M $ | |
| JADE BIOSCIENCES INC | 185 011 | 2,6 M $ | |
| C4 Therapeutics Inc | 856 353 | 2,3 M $ | |
| Avita Medical Inc | 544 895 | 2 M $ | |
| KalVista Pharmaceuticals Inc | 94 400 | 1,9 M $ | |
| IMAGENEBIO INC | 378 556 | 1,9 M $ | |
| VISTAGEN THERAPEUTICS INC | 3 060 000 | 1,7 M $ | |
| AtaiBeckley Inc | 347 000 | 1,2 M $ | |
| TRAWS PHARMA INC | 605 531 | 1,1 M $ | |